Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 375 results
March 2015
February 2015
-
Why research into rare diseases matters
Hundreds of millions of people worldwide await treatments for rare diseases.
-
Chemical genetics: The sleuthing behind modern drug discovery
Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.
-
Researchers aim to beat trick play by tumors with drug combo
January 2015
December 2014
-
Talking to: Juergen Brokatzky-Geiger, Global Head of Corporate Responsibility at Novartis
In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.
-
A fresh look at fighting glaucoma
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
Pagination
- ‹ Previous page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- › Next page